Showing results (1551-1560 of 1,580) with videos related to
Sort By:
Pageof 158
Journal of Medicinal Chemistry|January 27, 2007
Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine Tie-2 kinase inhibitorBrian L Hodous, Stephanie D Geuns-Meyer, Paul E Hughes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 23, 2023
Uptake of Genetic Research Results and Patient-Reported Outcomes With Return of Results Incorporating Web-Based Predisclosure EducationMadison Kilbride, Brian L Egleston, Wendy K Chung, et al.Pharmacogenomics|December 19, 2009
Institutional profile. UNC Institute for Pharmacogenomics and Individualized Therapy: interdisciplinary research for individual careTejinder K Rakhra-Burris, J Todd Auman, Patricia Deverka, et al.Journal of Medicinal Chemistry|April 23, 2008
Discovery and optimization of triazolopyridazines as potent and selective inhibitors of the c-Met kinaseBrian K Albrecht, Jean-Christophe Harmange, David Bauer, et al.Journal of Pharmaceutical Innovation|June 9, 2022
FDA Approaches in Monitoring Drug Quality, Forces Impacting the Drug Quality, and Recent Alternative Strategies to Assess Quality in the US Drug SupplyPhilip J Almeter, James T Isaacs, Aaron N Hunter, et al.Journal of Medicinal Chemistry|April 20, 2013
Rational design and binding mode duality of MDM2-p53 inhibitorsFelix Gonzalez-Lopez de Turiso, Daqing Sun, Yosup Rew, et al.The Journal of Clinical Investigation|May 18, 2021
GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese miceRicardo J Samms, Michael E Christe, Kyla Al Collins, et al.Journal of the National Cancer Institute|March 1, 2018
Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test ResultsAngela R Bradbury, Linda J Patrick-Miller, Brian L Egleston, et al.Journal of Medicinal Chemistry|March 8, 2014
Novel inhibitors of the MDM2-p53 interaction featuring hydrogen bond acceptors as carboxylic acid isosteresAna Z Gonzalez, Zhihong Li, Hilary P Beck, et al.Cancer Cell|September 22, 2023
ZNF683 marks a CD8<sup>+</sup> T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndromeErin M Parry, Camilla K Lemvigh, Stephanie Deng, et al.Pageof 158